U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a new federal initiative to build a comprehensive autism data platform using Medicare and Medicaid records. Designed to study the causes of autism spectrum disorder (ASD), the platform will integrate claims data, electronic health records, and data from wearable health devices, according to the Department of Health and Human Services (HHS).
The National Institutes of Health (NIH) and the Centers for Medicare and Medicaid Services (CMS) will collaborate on the effort, which is part of a broader $50 million research initiative to investigate potential environmental and medical causes of autism. Kennedy stated the project aims to provide "honest answers families have waited far too long to hear," despite his controversial history promoting a debunked link between vaccines and autism.
HHS said the platform will help researchers analyze autism diagnoses, treatment outcomes, healthcare access disparities, and the financial impact on families. However, experts like Dr. Helen Tager-Flusberg of Boston University argue the focus does not directly address autism’s root causes. She also noted that an existing NIH autism database recently went offline without explanation, raising concerns about transparency.
The project has sparked privacy questions, as HHS has not confirmed whether the database will be anonymous or voluntary. Autism researcher Eric Rubenstein noted that Medicaid and Medicare data offer insights into health disparities but lack environmental exposure data, which Kennedy claims he will explore.
Autism rates have surged in recent years, with the CDC reporting 1 in 31 U.S. 8-year-olds diagnosed in 2022. While Kennedy aims to identify autism’s causes by September, scientists emphasize that autism likely stems from a complex mix of genetic and environmental factors. Critics warn against oversimplifying this ongoing scientific challenge.


UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
India Plans Tax Reforms to Boost Foreign Investment and Manufacturing
Trump Education Department Removes Disparate Impact Rules, Sparking Civil Rights Backlash
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
25 Democratic-Led States Sue Trump Administration Over New Global Tariffs
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Appeals Court Rejects Trump Bid to Reinstate $100,000 H-1B Visa Fee
Trump Administration Weighs Executive Order on Vaccines and Autism Research
SEC Moves to Dismiss Insider Trading Case Against Trump-Pardoned Terren Peizer
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
3 clinical-grade skincare creams you really shouldn’t buy online
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Brazil Rejects Visas for Trump Officials Ahead of Presidential Election 



